Endpoints: 28,729MCP servers: 18,413Payout addresses: 2,071Paid calls: 1,561Letters: 14Defects: 1,336counted 4 min ago
teppi

Endpoint · inferenceGETx402-filings.datalayer.workers.dev/v1/health/clinical-trials?condition=melanoma&intervention=pembrolizumab&limit=25&phase=PHASE3&sponsor=Novartis&stoppedOnly=true

Stopped clinical trials with the stop reason classified.
Read moreStopped clinical trials with the stop reason classified. ClinicalTrials.gov records why a trial halted as free text; this reads that text and separates safety and efficacy failures from business, recruitment and funding stops, which are the ones people routinely misread as drug failures. Filter by sponsor, condition, intervention and phase, and get the cohort-level breakdown alongside the records.
UNRATEDDelisted

Overview

Grade?
UNRATED
0 of 30 paid calls toward a letter
Price
$0.02 per call
Paid calls
none yet
delivery unknown until someone pays

More info

URL
https://x402-filings.datalayer.workers.dev/v1/health/clinical-trials?condition=melanoma&intervention=pembrolizumab&limit=25&phase=PHASE3&sponsor=Novartis&stoppedOnly=true
Seen
first 35 days ago · last 18 days ago
45 free handshakes

Payment

Pays through
x402
Offered on?
Base USDC
Listed on?
Base

Handshakescomputed 13 days ago

0.781 from 43 free handshakes over 30 days · UNRATED ?

How the composite of 0.781 is made up, part by part
ComponentWeightMeasuredLower bound ?AddsShort ?Uncertain ?
latency p95costs the most
it answered as fast as its class
0.20 0.62 0.335
0.067 −0.076−0.057
liveness
it answered at all
0.60 1.00 0.857
0.514 0−0.086
price stability
the price stayed where it was listed
0.20 1.00 1.000
0.200 00
Composite1.000.781gap to 1.000 = 0.219 · 0.076 short · 0.143 uncertain0.781−0.076−0.143

Not measured: correctness · nobody paid; honesty · nobody paid; schema conformance · no answer had a published shape to check

BURN_INFREE_TIER_ONLY
Verify it yourselfnpx teppi-check https://x402-filings.datalayer.workers.dev/v1/health/clinical-trials?condition=melanoma&intervention=pembrolizumab&limit=25&phase=PHASE3&sponsor=Novartis&stoppedOnly=truecurl -s https://api.teppi.xyz/v1/trust/cap_01M1A59XTWH66SE05QXRPQ97S8